Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-17 Daniell Richard Exec. VP, European Commercial Option exercise +1,297 1,297
2019-03-17 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −1,297 1,297
2019-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +2,358 5,332.39
2019-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −2,358 2,359
2019-03-17 McClellan Michael James EVP, Chief Financial Officer Option exercise +660 12,990.27
2019-03-17 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −660 661
2019-03-17 Griffin Deborah A Chief Accounting Officer Option exercise +943 943
2019-03-17 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −943 944
2019-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +747 16,840.51
2019-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +265 17,105.51
2019-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −747 748
2019-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −265 266
2019-03-17 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,179 9,780.7
2019-03-17 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,179 1,179
2019-03-12 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +2,444 5,418.39
2019-03-12 Stark David Matthew Exec. VP Chief Legal Officer Sale −2,444 $15.82 $39K 2,974.39
2019-03-12 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −2,444 0
2019-03-12 O'Grady Brendan P. EVP, North America Commercial Option exercise +738 2,126.49
2019-03-12 O'Grady Brendan P. EVP, North America Commercial Sale −738 $15.67 $12K 1,388.49
2019-03-12 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −738 0

Page 65 of 76 · 1,517 trades